117 related articles for article (PubMed ID: 36081275)
1. Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran.
Taziki M; Rajaei S; Firouzei G; Hashemzadeh F; Rajabalian M; Mansoury M; Sedaghat S; Ghahraman F; Ghasemi-Kebria F; Weiderpass E; Roshandel G
Cancer Epidemiol; 2022 Oct; 80():102247. PubMed ID: 36081275
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Head and Neck Cancers in Northern Iran: A 10-Year Trend Study From Golestan Province.
Taziki MH; Fazel A; Salamat F; Sedaghat SM; Ashaari M; Poustchi H; Shakeri R; Hoseinpoor R; Hasanpour-Heidari S; Roshandel G
Arch Iran Med; 2018 Sep; 21(9):406-411. PubMed ID: 30221531
[TBL] [Abstract][Full Text] [Related]
3. Temporal and Geographical Trends of Incidence of Thyroid Cancer in Golestan, Iran, 2004-2013.
Salamat F; Aryannia A; Rajaei S; Naeimi-Tabiei M; Afghani R; Sedaghat SM; Naeimi-Tabiei E; Salamat F; Hosseinpour R; Fazel A; Araghi M; Roshandel G
Arch Iran Med; 2021 Jan; 24(1):1-6. PubMed ID: 33588561
[TBL] [Abstract][Full Text] [Related]
4. Incidental cervical metastases from thyroid carcinoma during neck dissection.
Périé S; Torti F; Lefevre M; Chabbert-Buffet N; Jafari A; Lacau St Guily J
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Dec; 133(6):383-386. PubMed ID: 27474239
[TBL] [Abstract][Full Text] [Related]
5. Thyroid carcinoma associated with squamous cell carcinoma of the head and neck: which policy?
Guzzo M; Quattrone P; Seregni E; Bianchi R; Mattavelli F
Head Neck; 2007 Jan; 29(1):33-7. PubMed ID: 16983696
[TBL] [Abstract][Full Text] [Related]
6. Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma.
Chen JH; Yen YC; Chen TM; Yuan KS; Lee FP; Lin KC; Lai MT; Wu CC; Chang CL; Wu SY
Cancer Med; 2017 Jan; 6(1):142-153. PubMed ID: 27987269
[TBL] [Abstract][Full Text] [Related]
7. Endocrine cancer in Iran: based on cancer registry system.
Haghpanah V; Soliemanpour B; Heshmat R; Mosavi-Jarrahi AR; Tavangar SM; Malekzadeh R; Larijani B
Indian J Cancer; 2006; 43(2):80-5. PubMed ID: 16790945
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis.
Lee JJW; Kunaratnam V; Kim CJH; Pienkowski M; Hueniken K; Sahovaler A; Lam ACL; Davies JC; Brown CM; De Almeida JR; Huang SH; Waldron JN; Spreafico A; Hung RJ; Xu W; Goldstein DP; Liu G
Cancer; 2023 Mar; 129(6):867-877. PubMed ID: 36653915
[TBL] [Abstract][Full Text] [Related]
9. Effect of a second primary thyroid carcinoma on patients with head and neck squamous cell carcinoma.
Tolisano AM; Klem C; Lustik MB; Sniezek JC; Golden JB
Head Neck; 2016 Apr; 38 Suppl 1():E890-4. PubMed ID: 25965105
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
[TBL] [Abstract][Full Text] [Related]
11. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
[TBL] [Abstract][Full Text] [Related]
13. Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.
Chen JH; Yen YC; Yang HC; Liu SH; Yuan SP; Wu LL; Lee FP; Lin KC; Lai MT; Wu CC; Chen TM; Chang CL; Chow JM; Ding YF; Wu SY
Medicine (Baltimore); 2016 Apr; 95(14):e3268. PubMed ID: 27057882
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
15. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
Trials; 2014 Nov; 15():469. PubMed ID: 25432788
[TBL] [Abstract][Full Text] [Related]
16. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
17. Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV.
Mazul AL; Hartman C; Kramer J; White DL; Royse K; Raychaudhury S; Sandulache V; Ahmed ST; Richardson P; Sikora AG; Chiao E
Cancer Med; 2020 Dec; 9(24):9326-9335. PubMed ID: 33094910
[TBL] [Abstract][Full Text] [Related]
18. Population-based cancer survival in the Golestan province in the northeastern part of Iran 2007-2012.
Nemati S; Saeedi E; Roshandel G; Nahvijou A; Badakhshan A; Akbari M; Sedaghat SM; Hasanpour-Heidari S; Hosseinpour R; Salamat F; Lotfi F; Khosravi A; Soerjomataram I; Bray F; Zendehdel K
Cancer Epidemiol; 2022 Apr; 77():102089. PubMed ID: 35042146
[TBL] [Abstract][Full Text] [Related]
19. Risk of obstructive sleep apnea after treatment of head and neck squamous cell carcinoma: a cross-sectional study.
Gavidia R; Dunietz GL; O'Brien LM; Schütz SG; Spector ME; Swiecicki PL; Chervin RD
J Clin Sleep Med; 2022 Jun; 18(6):1681-1686. PubMed ID: 35236549
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
